Terms: = Leukemia AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Diagnosis
2 results:
1. Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid leukemia.
Frikha R; Kassar O; Elloumi M; Kamoun H
J Oncol Pharm Pract; 2022 Dec; 28(8):1826-1831. PubMed ID: 34846219
[TBL] [Abstract] [Full Text] [Related]
2. Targeting acute myeloid leukemia cells by CD33 receptor-specific MoS
Štefík P; Annušová A; Lakatoš B; Elefantová K; Čepcová L; Hofbauerová M; Kálosi A; Jergel M; Majková E; Šiffalovič P
Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280914
[TBL] [Abstract] [Full Text] [Related]
